Company
Synnovation Therapeutics
Synnovation is dedicated to the discovery and development of Best-In-Class targeted medicines.
Also known as Synnovation Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Synnovation Therapeutics, Inc.
- synnovationtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are dedicated to the discovery and development of best-in-class therapeutics that can improve the lives of patients. Leveraging our deep expertise in biology and a world class medicinal chemistry team, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming care through patient-focused precision medicine.
Funding snapshot
- Total raised
- $107MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $102M2024-01-24
Funding rounds
- Round, 2024
- $102M2024-01-24, Company stated
- Round, 2023
- $69.9M2023-12-08, SEC form D sold, 7 investors
- Round, 2023
- $25M2023-05-17, SEC form D sold, 4 investors
- Round, 2021
- $12M2021-11-19, SEC form D sold, 1 investor
Loading relationship preview